Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
Roche’s gene therapy unit Spark has added to its pipeline in inherited retinal diseases (IRDs) with a $216 million alliance with Spanish biotech SpliceBio. Under the terms of the deal, Spark will get ...
Recent studies have uncovered the extent and pattern of conservation of intron position across widely diverged eukaryotic species. Introns that are found in the genomes of modern species are mainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback